Cancer

Title Average Ratingsort descending
WHO’S AFRAID OF A CURE FOR CANCER? - The struggle for an alternative cancer drug 90.00%
Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. 90.00%
Albumin Concentration Controls Cancer 90.00%
Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure 90.00%
Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins. 90.00%
71 year old woman, Pancraetic cancer with liver and lung metastasis. 90.00%
Efficacy of homeopathic therapy in cancer treatment 90.00%
Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. 90.00%
Opioid growth factor and the treatment of human pancreatic cancer: a review. 90.00%
Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. 90.00%
Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. Sub-category: Cell-Based Therapy 90.00%
Hyperthermia adds to chemotherapy. 90.00%
Metabolic modulation of glioblastoma with dichloroacetate. 90.00%
Clinical Investigations on Ukrain 90.00%
Open Source Cancer Resaearch - A video 90.00%
Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis. 90.00%
Role of infectious agents in the emergence of malignant tumors 90.00%
The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alp 90.00%
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. 90.00%
Dendritic cell-based vaccination in combination with gemcitabine/S-1 in patients with advanced pancreatic cancer. Sub-category: 90.00%
Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic soli 90.00%
Pre-Clinical Investigations on Ukrain 90.00%
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic ca 90.00%
Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis. 90.00%
Adaptive therapy. 90.00%
71 year old woman. Breast cancer with bone metastasis 90.00%
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor acti 90.00%
Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer. 90.00%
Therapeutic vaccination with an autologous TriMix-Dendritic cell vaccine combined with sequential interferon alfa-2b in ........ 90.00%
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. 90.00%
20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and 90.00%
Treatment of advanced pancreatic cancer with opioid growth factor: phase I. 90.00%
Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's .... 90.00%
In-vitro toxicity of Ukrain against human Ewing tumor cell lines. 90.00%
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced esoph 90.00%
Debate in Lancet about setting up a phase II trial on Ukrain in England 90.00%
Vitamin D for cancer prevention: global perspective. 90.00%
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell 90.00%
Case Report: A Breast Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Hormone Therapy 90.00%
Artesunate in the treatment of metastatic uveal melanoma--first experiences. 90.00%
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). 90.00%
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy. 90.00%
A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. 90.00%
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a 90.00%
Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. 90.00%
Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potent 90.00%
Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer. 90.00%
Ukrain - a new cancer cure? A systematic review of randomised clinical trials. 90.00%
Tumor therapy with Amanita phalloides (death cap): stabilization of B-cell chronic lymphatic leukemia. 90.00%
42 year old man. Kidney cancer 90.00%
Artemisinin derivates in the treatment of Cancer 90.00%
Dichloroacetic acid 90.00%
Metronomic schedule of temozolomide with conventional dose of cisplatin in metastatic melanoma. Sub-category: Melanoma Categor 90.00%
Why We Get Sick And How to Get Well 90.00%
Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer. 90.00%
Is it time to test metformin in breast cancer clinical trials? 90.00%
The present state of antineoplaston research (1) 90.00%
Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice 90.00%
Effects of CANELIM capsule drug-contained serum on viscoelasticity 90.00%
The use of mushroom glucans and proteoglycans in cancer treatment. 90.00%
Medicinal plants and cancer chemoprevention. 90.00%
Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced 90.00%
Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, 90.00%
The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications 90.00%
Why are tumour blood vessels abnormal and why is it important to know? 90.00%
Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study. 90.00%
A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside. 90.00%
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized ........ 90.00%
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer. 90.00%
Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. 90.00%
Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis. 90.00%
Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors 90.00%
Chemotherapy of advanced epithelial cancer--a critical review 90.00%
MR-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: preliminary results in 16 patients. 90.00%
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. 90.00%
Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. 90.00%
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia. 90.00%
Mistletoe therapy in oncology 90.00%
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. 90.00%
Metronomic chemotherapy: changing the paradigm that more is better. 90.00%
Psorinum, the anti cancer miracle from India. 91.47%
Low-dose naltrexone for disease prevention and quality of life. 95.00%
Phase II study of docetaxel-prednisone (DP) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) ...... 95.00%
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up. 95.00%
Ukrain (NSC-631570) in the treatment of pancreas cancer. 95.00%
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. 95.00%
Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. 95.00%
Bio-Immune therapy according to Professor Thomas Tallberg, a cure for Melanoma? 97.50%
DCA 97.50%
Why is not Ukrain approved yet in Austria/EU? 98.57%
Deuterium depleted water effects on survival of lung cancer patients and expression of Kras, Bcl2, and Myc genes in mouse lung. 100.00%
IS THERE A COVID VACCINE / CANCER CONNECTION? 100.00%
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with unresectable metastatic colorectal carcinoma. 100.00%
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced non-s 100.00%
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with metastatic bladder cancer. 100.00%
CLINICAL EXPERIENCE OF CANCER IMMUNOTHERAPY INTEGRATED WITH OLEIC ACID COMPLEXED WITH DE-GLYCOSYLATED VITAMIN D BINDING PROTEIN 100.00%
A prospective observational clinical study involving an alternative cancer treatment, psorinum therapy, in treating stomach, gal 100.00%
Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma. 100.00%
63 year old woman with stage III malignant melanoma 100.00%
Stoppa Massmordet! 100.00%

Pages